Sara Zawoyski
Analyst · KeyBanc Capital Markets. Please go ahead with your question
Thank you, Beth. Let's turn to Slide 4 to review second quarter 2020 results. Sales was $447 million were down 17% relative to last year on a reported basis and declined 22% organically. The acquisitions of Eldon and WBT added about six points to growth. Looking at monthly trends overall during the quarter, daily organic sales year-over-year were fairly consistent by month, with the marginal improvement in June. Notably organic orders declined labs and sales at down 15%. Second quarter decrementals were 39% all in including a 7 point negative impact from acquisitions. So, better than our initial outlook. We executed well on our scenario plans including both structural and temporary cost actions while investing in future growth. Free cash flow continued to improve versus prior year and we had a strong conversion in the quarter at approximately 160% Now, please turn to Slide 5 for a discussion of our second quarter segment performance. Starting with Enclosures, sales of $219 million declined 16% and 25% organically. While COVID-19 negatively impacted demand across most verticals, we did see pockets of relative strength and we grew low double-digits in rail. Price was negative in the quarter as we won some competitive new business. While Eldon sales declined, we expanded margin over 300 basis points on a pro forma basis and are well on track with our integration efforts. Enclosures segment income declined 41% and return on sale declined 560 basis points. The impact of lower volume, inefficiencies and increased costs related to COVID-19 negatively impacted margins. Decrementals are expected to improve in the back half of the year. Moving to Thermal Management; sales of $96 million declined 24% organically. As expected, industrial MRO saw the steepest declines due to continued site closures in parts of the world and delayed or deferred spend. Our project business was down single-digits as we continue to execute on our backlog. In addition, we grew backlog sequentially and year-over-year as we continue to win major project bookings. Recall, the vast majority of our energy exposure is downstream which seems to be faring better in this environment. Commercial revenue experienced significant declines in the first part of the quarter. However, saw a modest recovery in June and we continue to make good progress expanding our channel presence with our commercial offering. Segment income was down 43% and return on sales declined 460 basis points due to lower volume in industrial MRO and commercial which tend to have a higher margin mix component. We saw a significant sequential improvement in decrementals from Q1 as the actions to reduce our fixed cost structure and realign our business, are read out. Now on to EFS; sales of $132 million declined 12% and 14% organically. The commercial vertical was negatively impact by COVID-19 mainly due to site shutdown. An area of particular strength in the quarter was in the utilities vertical, which grew mid-single digits and accounts for nearly 10% of EFS sales. Segment income was down 17% and return on sales declined 130 basis points, but remained strong at over 26%. EFS had almost a point of contribution from price and realized strong productivity gains, which helped offset operational inefficiencies from COVID-19. Turning to Slide 6. The team executed well on the cost actions through a combination of restructuring and temporary actions. The growth continues to lag and uncertainty remains, we implemented additional cost actions. In aggregate, we are now targeting approximately $70 million of cost savings versus the original $50 million we discussed on the April earnings call. These actions include an extension of the temporary measures we took in the second quarter as well as more structural changes. Reviewing our near-term capital allocation strategy, we will continue to invest first inorganic growth with a focus on new product development and our digital transformation. Our dividend remains a key component of returning cash to shareholders. We are lifting the suspension of our share buyback program, and we'll continue to assess buyback stock -- buying back stock based on market conditions and M&A opportunities. On M&A, we are focused on actively building relationships in our funnel, so that we are in a position to be ready as market conditions improve. As always, we will continue to evaluate the returns for each capital allocation decision with the goal to generate the highest return, while managing liquidity and leverage. Moving to Slide 7, titled Healthy Liquidity Position. Our net leverage ratio at the end of the second quarter was 2.4 times, which is slightly above the first quarter. We ended the quarter with $235 million in cash and an additional $315 million available on our revolver. We have limited maturities until 2023 and remain confident in our liquidity position, as well as our cash generation activities this year. Specifically on working capital, our team continued to make good progress. Our working capital task force is taking a data driven approach to target opportunities, grading structural improvements to benefit our cash generation in future periods. We did see an uptick in inventory early in the quarter given the steep decline in demand but made progress and expect this to continue to improve in the back half of the year. This focus on working capital is another example of how we intend to emerge stronger from this pandemic. On Slide 8 titled Balance Sheet and Cash Flow. We have a healthy balance sheet and as I mentioned earlier, we are seeing improved year-over-year cash generation. In the second quarter, we focused on liquidity preservation, while also deploying $30 million to dividends, and approximately $7 million to CapEx. Moving to Slide 9. Consistent with what we first presented in April, we continue to manage our business through scenario plans and actions at all levels of the organization. While we believe the worst is behind us, the shape and pace of the recovery remains unclear. Accordingly, we are continuing the suspension of our full financial guidance until the market conditions stabilize. More near-term, we do expect third quarter organic sales to be down in the 10% to 20% range, so an improvement from the second quarter. A couple data points that gives us reasons to believe sales can improved. First, orders declined less than sales in the second quarter and down 15%. Additionally, both June and July orders were down mid-teens showing improvement from the May trough. We also saw an improvement in July sales versus second quarter trends. We expect decrementals to further improve in the third quarter and to be in the range of 25% to 30% before acquisition. As cost actions and improved efficiencies continue to read out. For the full year 2020, we continue to see sales down between the mild and moderate scenarios. As we progress through the rest of the year, we expect sequential improvement in each of our segments, albeit still down year-over-year. Again, these are scenarios that we have modeled at enterprise, at segment and at each of our plants, help ensure we have the plans in place and we are ready to execute. As a reminder, these scenarios exclude the impact from acquisitions. A few other points as guideposts for full year 2020. We now expect interest to be in the approximately $40 million range and a tax rate in the 17% to 18% range. On shares, if we did not buyback any more this year, our diluted share count will be close to $171 million. Our focus is on actively managing decrementals, driving cash and deliver and recovering fast. I am confident that we are taking the appropriate actions to create a stronger nVent as we emerge. And I am pleased with our second quarter results and execution, amidst this challenging environment. This concludes my comments on the second quarter and I will now turn the call back over to Beth.